Avalo Therapeutics (AVTX) Q4 2024 Earnings

Nov 7Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-141
-94.04
-47.07
-0.11

Details

Expected EPS
-1.19
Actual EPS
-2.83
Surprise EPS
-1.64
Surprise Percent
-137.82%

Description

⁨Avalo Therapeutics⁩ (⁦AVTX⁩) has reported earnings of ⁦-2.83⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts